Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating if using lung ultrasound can safely improve the treatment of lung infections in children aged 2 months to 12 years. The study focuses on community-acquired pneumonia, a leading cause of illness and death in children, especially in low-resource settings. It aims to see if lung ultrasound can help doctors better decide which children actually need antibiotics, reducing unnecessary antibiotic use and addressing concerns about antibiotic resistance and health risks from overuse. Participants will be randomly assigned to one of two groups one receiving routine care without ultrasound, and the other undergoing lung ultrasound where images are reviewed by experts to guide antibiotic use. Children in the ultrasound group may avoid antibiotics if the scan indicates no bacterial infection. The study excludes children who are very unwell or have had more than 2 days of antibiotics. This approach aims to integrate lung ultrasound into existing pneumonia management guidelines. Throughout the study, children will be assessed at several points including day 1 and day 8 for antibiotic prescription and clinical outcomes, with follow-up extending to day 29 and up to 8 weeks for tuberculosis-related assessments. Researchers will monitor antibiotic use, clinical failure, adverse reactions, hospital admissions, and diagnoses including bacterial pneumonia and tuberculosis. The study tracks health outcomes and the potential impact of ultrasound on treatment decisions, with the total participation duration varying by participant condition and follow-up needs.